https://wikimd.org/index.php?action=history&feed=atom&title=PhenanthriplatinPhenanthriplatin - Revision history2026-04-25T17:09:01ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=Phenanthriplatin&diff=5368542&oldid=prevPrab: CSV import2024-03-06T04:06:44Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:Phenanthriplatin.png|thumb|{{PAGENAME}}]]<br>'''Phenanthriplatin''' is a [[platinum]]-based [[anticancer drug]] that is part of the [[platinum compounds]] family. It was developed as a potential alternative to the widely used [[cisplatin]], [[carboplatin]], and [[oxaliplatin]]. <br />
<br />
== History ==<br />
<br />
Phenanthriplatin was first synthesized and studied by researchers at [[Massachusetts Institute of Technology]] (MIT) in 2012. The research was led by [[Stephen J. Lippard]], a renowned chemist known for his work on platinum-based anticancer drugs.<br />
<br />
== Structure and Mechanism of Action ==<br />
<br />
Phenanthriplatin is a monofunctional platinum(II) complex, which means it binds to [[DNA]] at only one site. This is in contrast to cisplatin and its derivatives, which are bifunctional and bind to DNA at two sites. The structure of phenanthriplatin includes a [[phenanthridine]] ligand, which is responsible for its unique properties.<br />
<br />
The mechanism of action of phenanthriplatin involves forming a covalent bond with the DNA, causing it to bend and distorting its normal shape. This distortion interferes with the DNA's ability to replicate and transcribe, which in turn inhibits the growth and proliferation of cancer cells.<br />
<br />
== Efficacy and Side Effects ==<br />
<br />
In preclinical studies, phenanthriplatin has shown to be up to 40 times more potent than cisplatin. It has also demonstrated activity against cancer cells that are resistant to cisplatin.<br />
<br />
Like all platinum-based anticancer drugs, phenanthriplatin can cause side effects. These can include [[nausea]], [[vomiting]], [[kidney damage]], and [[neurotoxicity]]. However, the severity and incidence of these side effects can vary depending on the specific drug and the patient's individual response.<br />
<br />
== Current Status ==<br />
<br />
As of now, phenanthriplatin is still in the experimental stage and has not been approved for use in humans. Further research and clinical trials are needed to fully understand its efficacy and safety profile.<br />
<br />
== See Also ==<br />
<br />
* [[Platinum-based antineoplastic]]<br />
* [[Cisplatin]]<br />
* [[Carboplatin]]<br />
* [[Oxaliplatin]]<br />
<br />
[[Category:Anticancer drugs]]<br />
[[Category:Platinum compounds]]<br />
[[Category:Experimental drugs]]<br />
{{Chemistry-stub}}<br />
{{Pharmacology-stub}}</div>Prab